What Researchers Did
Researchers reported on a case of a woman with a rhino-cerebral fungal infection that was successfully treated with supplementary hyperbaric oxygen therapy after initial antifungal treatment failed.
What They Found
A woman presented with left trigeminal neuralgia, ophthalmoplegia, and blindness, with MRI revealing a lesion of the left orbital apex and cavernous sinus. Biopsy confirmed fungal infiltration (aspergillosis or mucormycosis), and after six weeks of high-dose liposomal Amphotericin B (5mg/kg/day) proved unsuccessful, supplementary hyperbaric oxygen therapy led to clinical and radiological improvement.
What This Means for Canadian Patients
For Canadian patients suffering from severe rhino-cerebral fungal infections that do not respond to conventional antifungal medications, hyperbaric oxygen therapy might offer an alternative treatment option. This approach could potentially improve outcomes in difficult-to-treat cases, especially when standard therapies are insufficient.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
The primary limitation of this study is its design as a single case report, which limits the generalizability of its findings to a broader patient population.